An evidence mapping and analysis of registered COVID-19 clinical trials in China.

ABSTRACT:

Background

This article aims to summarize the key characteristics of registered trials of 2019 novel coronavirus (COVID-19), in terms of their spatial and temporal distributions, types of design and interventions, and patient characteristics among others.

Methods

A comprehensive search of the registered COVID-19 trials has been performed on platforms including ClinicalTrials.gov, WHO International Clinical Trials Registry Platform (WHO ICTRP), Chinese Clinical Trials Registry (CHiCTR), Australian Clinical Trials Registry, Britain's National Research Register (BNRR), Current Control Trials (CCT), and Glaxo Smith Kline Register. Trials registered at the first 8 weeks of the COVID-19 outbreak are included, without language restrictions. For each study, the registration informat

SUBMITTER: Lu L 

PROVIDER: S-EPMC7268588 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature